![]() |
About us | Subscription | e-Alerts | Feedback | Login | |
![]() ![]() ![]() ![]() ![]() |
||
Home | Current Issue
| Archives| Ahead of print
| Search |Instructions ![]() |
||
|
||
|
Download PDF Efficacy and outcomes of CYP3A5 genotype-based tacrolimus dosing compared to conventional body weight-based dosing in living donor kidney transplant recipients
|
|